Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products
Advertisement
Advertisement
Trending on AJMC
1
Congress Unveils Massive Funding Bill to Avert Shutdown
2
Gates Foundation, OpenAI Launch $50M AI Health Initiative in Africa
3
By Improving Sleep, TNX-102 SL Reduces Pain and Fatigue in Fibromyalgia
4
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
5
